Literature DB >> 11801836

von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury.

L B Ware1, E R Conner, M A Matthay.   

Abstract

OBJECTIVE: The primary objective of this study was to test the hypothesis that the degree of systemic endothelial activation, as measured by the release of von Willebrand factor antigen into the circulation and pulmonary edema fluid, is an important determinant of outcome from acute lung injury and acute respiratory distress syndrome.
DESIGN: Observational study.
SETTING: Intensive care unit patients in a tertiary university hospital and a university-affiliated city hospital. PATIENTS: Fifty-one intubated, mechanically ventilated intensive care unit patients with acute lung injury or acute respiratory distress syndrome as defined by the North American European Consensus Conference definitions.
INTERVENTIONS: Undiluted pulmonary edema fluid and plasma were collected within 1 hr of endotracheal intubation in all patients. MEASUREMENTS: von Willebrand factor antigen concentrations and protein concentration were measured in pulmonary edema fluid and in plasma. MAIN
RESULTS: At the time of intubation, median plasma von Willebrand factor antigen was 251%, two-fold higher than the median pulmonary edema fluid von Willebrand factor antigen of 130%. Median edema fluid and plasma von Willebrand factor antigen concentrations were significantly higher in patients who did not survive hospitalization. Plasma von Willebrand factor antigen was also higher in those patients who had a longer duration of mechanical ventilation (as measured by ventilator-free days). Plasma von Willebrand factor antigen was also significantly higher in patients with sepsis and two or more organ system failures. According to stepwise logistic regression analysis, plasma von Willebrand factor antigen was independently associated with in hospital death. The positive predictive value for death if the plasma von Willebrand factor antigen concentration was >450% was 83%. A plasma von Willebrand factor antigen concentration of >450% previously has been shown to predict the development of acute respiratory distress syndrome.
CONCLUSIONS: These findings suggest that the degree of systemic endothelial activation and injury at the onset of acute lung injury is an important determinant of the outcome from acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11801836     DOI: 10.1097/00003246-200112000-00016

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  47 in total

Review 1.  The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology.

Authors:  K Atabai; M A Matthay
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 2.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

3.  Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation.

Authors:  Heidi R Flori; Lorraine B Ware; Meredith Milet; Michael A Matthay
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

Review 4.  Acute lung injury: epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth R Johnson; Michael A Matthay
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

5.  Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients.

Authors:  Ashish Agrawal; Michael A Matthay; Kirsten N Kangelaris; John Stein; Jeffrey C Chu; Brandon M Imp; Alfredo Cortez; Jason Abbott; Kathleen D Liu; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

6.  Biomarkers in acute lung injury: are we making progress?

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

Review 7.  Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Authors:  Carolyn S Calfee; Mark D Eisner; Polly E Parsons; B Taylor Thompson; Edward R Conner; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

Review 8.  Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment.

Authors:  Michelle Ng Gong
Journal:  Clin Chest Med       Date:  2006-12       Impact factor: 2.878

9.  Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study.

Authors:  Shunsaku Takahashi; Norimasa Miura; Tomomi Harada; ZhongZhi Wang; Xinhui Wang; Hideyuki Tsubokura; Yoshiaki Oshima; Junichi Hasegawa; Yoshimi Inagaki; Goshi Shiota
Journal:  J Transl Med       Date:  2010-10-22       Impact factor: 5.531

10.  Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality.

Authors:  Melanie van der Heijden; Peter Pickkers; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Martijn P W J M Bouw; Johannes G van der Hoeven; A B Johan Groeneveld
Journal:  Intensive Care Med       Date:  2009-06-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.